OLD National Bancorp IN Acquires 29,051 Shares of Bath & Body Works, Inc. $BBWI

OLD National Bancorp IN increased its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 8.5% in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 371,573 shares of the company’s stock after buying an additional 29,051 shares during the quarter. OLD National Bancorp IN owned about 0.18% of Bath & Body Works worth $11,132,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC increased its holdings in Bath & Body Works by 38.9% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company’s stock worth $1,265,000 after buying an additional 11,681 shares in the last quarter. Merit Financial Group LLC bought a new stake in Bath & Body Works in the 1st quarter worth about $714,000. Assenagon Asset Management S.A. increased its holdings in Bath & Body Works by 3,642.2% in the 1st quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company’s stock worth $50,062,000 after buying an additional 1,606,988 shares in the last quarter. IFM Investors Pty Ltd bought a new stake in Bath & Body Works in the 1st quarter worth about $1,314,000. Finally, Golden State Wealth Management LLC increased its holdings in Bath & Body Works by 94.7% in the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock worth $40,000 after buying an additional 642 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Trading Up 0.8%

Shares of NYSE:BBWI opened at $25.87 on Friday. The stock has a 50 day moving average of $28.42 and a 200 day moving average of $29.47. The company has a market cap of $5.33 billion, a PE ratio of 7.68, a price-to-earnings-growth ratio of 0.88 and a beta of 1.52. Bath & Body Works, Inc. has a 12-month low of $24.93 and a 12-month high of $41.87.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting analysts’ consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company had revenue of $1.55 billion for the quarter, compared to analysts’ expectations of $1.55 billion. During the same period in the previous year, the firm earned $0.37 EPS. The firm’s revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Equities research analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were issued a $0.20 dividend. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 3.1%. Bath & Body Works’s payout ratio is currently 23.74%.

Wall Street Analyst Weigh In

BBWI has been the subject of a number of recent research reports. Citigroup cut their price target on Bath & Body Works from $42.00 to $40.00 and set a “buy” rating for the company in a research note on Tuesday, August 19th. Morgan Stanley cut their price target on Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating for the company in a research note on Friday, September 12th. UBS Group cut their price target on Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating for the company in a research note on Friday, August 29th. Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a research note on Saturday, September 27th. Finally, Telsey Advisory Group restated an “outperform” rating and set a $38.00 price target on shares of Bath & Body Works in a research note on Thursday, August 28th. Twelve analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $39.69.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.